# A Novel E-health Platform

> **NCT05024903** · PHASE2,PHASE3 · TERMINATED · sponsor: **Daren K. Heyland** · enrollment: 31 (actual)

## Conditions studied

- Aging Well
- Decision Making
- Illness, Critical

## Interventions

- **OTHER:** Serious illness medical planning plus the novel e-health platform (PWG 2.0)
- **OTHER:** Standard of care

## Key facts

- **NCT ID:** NCT05024903
- **Lead sponsor:** Daren K. Heyland
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-10-01
- **Primary completion:** 2022-09-22
- **Final completion:** 2022-09-22
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** Unable to enroll enough patients in the time allotted. Study deemed infeasible.Dece
- **Last updated:** 2023-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05024903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05024903, "A Novel E-health Platform". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT05024903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*